The short answer is, ideally yes, but not completely. The animal models of cancer are poor at predicting how the drug will work in a human, but where they have value is in evaluation of drug safety. So, we envision that the toxicity studies would still be done in animals, but near-human, organ-specific models would ultimately replace animal studies of drug efficacy.